Skip to main content

Table 8 Policy-related drugs used after policy intervention

From: The impacts of national centralized drug procurement policy on drug utilization of medical institutions: an empirical study in a county-level hospital in China

No.

Round

Generic Name

Brand

Price Reduction

1

First

Entecavir tablets

Bid-winning

79.94%***

2

First

Cefuroxime axetil tablets

Bid-winning

74.86%***

3

Second

Azithromycin tablets

Bid-non-winning

/

4

Second

Levocetirizine dihydrochloride tablets

Bid-non-winning

/

5

Second

Fudosteine tablets

Bid-winning

62.59%***

6

Third

Cefdinir capsules

Bid-winning

84.77%***

7

Third

Mecobalamin tablets

Bid-winning

97.71%***

8

Fifth

Cisatracurium besylate injection

Bid-winning

83.13%***

  1. Retail price: the last online price of this drug in Jiangsu before the NCDP. If the drug was not sold online in Jiangsu, then the median online price of all other brands during the year before policy intervention was used
  2. * Price reduction = – (bid-winning price – retail price) /retail price *100%
  3. Standard errors in parentheses ** p<0.05, *** p<0.01